The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

A vaccine and monoclonal antibody injection to protect against RSV are both more widely available heading into this cold and ...

Last year, a prenatal maternal vaccine (Avrexy) and a long-lasting monoclonal antibody called nirsevimab were approved for ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

This year's headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines -- including a new ...

The Royal Australian College of GPs (RACGP) has lauded the Federal Government's announcement of $174.5 million to provide free RSV vaccination during ...

Some provinces have begun rolling out a vaccination program for infants with newly authorized products. The situation is much ...

A new government program will give pregnant mothers and newborns free access to RSV vaccines, a move that is expected to ...

If you do not receive your RSV vaccine during pregnancy, it is recommended that your baby receives monoclonal antibodies called Beyfortus through a single intramuscular injection that is expected to ...

Health care providers recommend flu and COVID-19 vaccinations for people six months and older; older adults and pregnant ...